EGFR-expression was associated with negative prognostic factors including ERα/PR-negativity, HER2-overexpression, high tumor stage, high Ki67, low age at diagnosis, lymph node metastasis, and larger tumor size at diagnosis. The gene discussed is ESR1; the disease is metastatic malignant neoplasm in the lymph nodes.